We are live on ! Find out more
ONCS

OncoSec Medical

Delisted

ONCS was delisted on the 23rd of June, 2023.

34 hedge funds and large institutions have $18.9M invested in OncoSec Medical in 2018 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

0.34% less ownership

Funds ownership: 26.49% → 26.15% (-0.34%)

3% less capital inflows, than outflows

Capital inflows: $2.73M | Capital outflows: $2.83M

11% less funds holding

Funds holding: 38 → 34 (-4)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
34
Holders Change
-4
Holders Change %
-10.53%
% of All Funds
0.78%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
10
Reduced
5
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ONCS Hedge Fund Activity: Q2 2018 in Review

34 of the 4,387 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical (ONCS) for Q2 2018, worth a combined $18.9M — down 26% from $25.6M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of ONCS and 7 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Nexthera Capital, adding an estimated $876K. The largest seller was Point72 Asset Management, cutting an estimated $1.59M.

  • 34 institutional investors held OncoSec Medical (ONCS) as of Q2 2018, down from 38 in Q1 2018.
  • Funds reported $18.9M of OncoSec Medical stock for Q2 2018, down 26% quarter-over-quarter.
  • 7 funds opened new OncoSec Medical positions in Q2 2018 and 10 closed out, a net change of -3 holders.
  • The largest OncoSec Medical buyer in Q2 2018 was Nexthera Capital, an estimated $876K added.
  • The largest OncoSec Medical seller in Q2 2018 was Point72 Asset Management, an estimated $1.59M sold.

Based on aggregated 13F filings for Q2 2018.